Sollice Biotech

Sollice Biotech Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 20
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.75M
Latest Deal Amount
  • Investors
  • 3

Sollice Biotech General Information


Provider of active ingredients intended for the cosmetics market. The company's ingredients are innovative high-performance and functional active ingredients which include molecules to formulate high-quality products, enabling its users with personal care innovative skincare products at an affordable price.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Personal Products
Primary Office
  • CS 21027
  • 24112 Bergerac
  • France
+33 05 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sollice Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 28-Jun-2018 $1.75M 00.000 00.00 Completed Generating Revenue

Sollice Biotech Cap Table

To view Sollice Biotech‘s complete cap table, request access »
Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000

Sollice Biotech Executive Team (3)

Name Title Board Seat Contact Info
Zsolt Rendetzki Co-Founder & Chief Executive Officer
Bruno Soulez Co-Founder & Chief Financial Officer
Siegfried Prive General Manager

Sollice Biotech Investors (3)

To view Sollice Biotech‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AQUITI Gestion Venture Capital Minority 000 0000 000000 0
Charente-Périgord Expansion PE/Buyout Minority 000 0000 000000 0
Le Conseil régional d'Aquitaine Other Minority 000 0000 000000 0

Ready to get started?

Request a free trial